Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Non-Current Assets (2016 - 2025)

iBio (IBIO) has disclosed Non-Current Assets for 15 consecutive years, with $11.0 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 17.71% to $11.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $50.9 million through Dec 2025, down 4.52% year-over-year, with the annual reading at $13.5 million for FY2025, 3.08% up from the prior year.
  • Non-Current Assets for Q4 2025 was $11.0 million at iBio, down from $13.4 million in the prior quarter.
  • The five-year high for Non-Current Assets was $59.0 million in Q4 2021, with the low at $11.0 million in Q4 2025.
  • Average Non-Current Assets over 5 years is $25.0 million, with a median of $14.5 million recorded in 2023.
  • The sharpest move saw Non-Current Assets soared 70.76% in 2021, then plummeted 76.99% in 2022.
  • Over 5 years, Non-Current Assets stood at $59.0 million in 2021, then tumbled by 76.99% to $13.6 million in 2022, then increased by 5.59% to $14.3 million in 2023, then decreased by 6.47% to $13.4 million in 2024, then dropped by 17.71% to $11.0 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $11.0 million, $13.4 million, and $13.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.